New York State Common Retirement Fund’s Adverum Biotechnologies ADVM Stock Holding History

New York State Common Retirement Fund’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,000	Closed	-$13K	–	3201
2025 Q1	$13K	Hold	3,000	–	–	﹤0.01%	3043
2024 Q4	$13.6K	Hold	3,000	–	–	﹤0.01%	3094
2024 Q3	$21K	Sell	3,000 -11,400	-79%	-$82.8K	﹤0.01%	3038
2024 Q2	$98.8K	Buy	+14,400	New	+$134K	﹤0.01%	2865
2022 Q3	–	Sell	-73	Closed	-$1K	–	3258
2022 Q2	$1K	Sell	73 -5,190	-99%	-$54.4K	﹤0.01%	3307
2022 Q1	$69K	Hold	5,263	–	–	﹤0.01%	3094
2021 Q4	$93K	Sell	5,263 -14	-0.3%	-$280	﹤0.01%	3093
2021 Q3	$115K	Buy	5,277 +15	+0.3%	+$383	﹤0.01%	3091
2021 Q2	$184K	Sell	5,262 -2,608	-33%	-$140K	﹤0.01%	3076
2021 Q1	$776K	Hold	7,870	–	–	﹤0.01%	2239
2020 Q4	$853K	Buy	7,870 +1,170	+17%	+$145K	﹤0.01%	2106
2020 Q3	$690K	Hold	6,700	–	–	﹤0.01%	2065
2020 Q2	$1.4M	Buy	6,700 +1,590	+31%	+$282K	﹤0.01%	1704
2020 Q1	$499K	Buy	5,110 +820	+19%	+$95.6K	﹤0.01%	2039
2019 Q4	$494K	Sell	4,290 -1,150	-21%	-$101K	﹤0.01%	2308
2019 Q3	$296K	Hold	5,440	–	–	﹤0.01%	2574
2019 Q2	$647K	Buy	5,440 +1,060	+24%	+$87.7K	﹤0.01%	2238
2019 Q1	$230K	Hold	4,380	–	–	﹤0.01%	2657
2018 Q4	$138K	Hold	4,380	–	–	﹤0.01%	2858
2018 Q3	$265K	Hold	4,380	–	–	﹤0.01%	2704
2018 Q2	$232K	Buy	+4,380	New	+$263K	﹤0.01%	2812
2017 Q2	–	Sell	-1,790	Closed	-$48K	–	3180
2017 Q1	$48K	Hold	1,790	–	–	﹤0.01%	3070
2016 Q4	$52K	Hold	1,790	–	–	﹤0.01%	3061
2016 Q3	$74K	Hold	1,790	–	–	﹤0.01%	3037
2016 Q2	$57K	Hold	1,790	–	–	﹤0.01%	3080
2016 Q1	$93K	Hold	1,790	–	–	﹤0.01%	2942
2015 Q4	$170K	Hold	1,790	–	–	﹤0.01%	2844
2015 Q3	$147K	Buy	1,790 +198	+12%	+$25.3K	﹤0.01%	2916
2015 Q2	$259K	Buy	1,592 +1,390	+688%	+$469K	﹤0.01%	2817
2015 Q1	$82K	Buy	+202	New	+$85.4K	﹤0.01%	2231

Other funds holding ADVM

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

PWA

Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

New York State Common Retirement Fund's ADVM Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Adverum Biotechnologies (ADVM) in Q2 2025, closing a stake of 3,000 shares — an estimated $13K sold.

New York State Common Retirement Fund first reported a position in ADVM in Q1 2015 and held it in 30 quarters. The position peaked at $1.4M in Q2 2020. 58 funds tracked by Wall St. Rank hold ADVM as of Q2 2025.

New York State Common Retirement Fund reported no remaining Adverum Biotechnologies position as of Q2 2025 after selling out during the quarter.
New York State Common Retirement Fund sold 3,000 Adverum Biotechnologies shares in Q2 2025, an estimated $13K.
New York State Common Retirement Fund first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 30 quarters.
New York State Common Retirement Fund's Adverum Biotechnologies position peaked at $1.4M in Q2 2020.
58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.